Dr. Calabrese is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10524 Euclid Ave, 12th floor
Cleveland, OH 44106Phone+1 216-844-2865Fax+1 216-844-2875- Is this information wrong?
Education & Training
- National Institutes of Health Clinical CenterResidency, Psychiatry, 1984 - 1986
- Cleveland Clinic FoundationResidency, Psychiatry, 1980 - 1984
- Ohio State University College of MedicineClass of 1980
- Xavier UniversityB.S., Biology, Summa Cum Laude, 1972 - 1976
Certifications & Licensure
- OH State Medical License 1981 - 2023
- MD State Medical License 1984 - 1986
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Distinguished Life Fellow American Psychiatric Association, 2016
- America's Top Doctors Castle Connolly, 2008-2014
- Highly Cited as being one of the world’s most influential scientific minds within the section entitled: “Psychiatry/Psychology” Thompson Reuters, 2014
- Join now to see all
Clinical Trials
- Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Start of enrollment: 2002 Jul 01
- Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD) Start of enrollment: 2011 Apr 01
- Sequential Multiple Assignment Treatment for Bipolar Disorder Start of enrollment: 2011 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Possible Role of Correlation Coefficients and Network Analysis of Multiple Intracellular Proteins in Blood Cells of Patients with Bipolar Disorder in Studying the Mech...Marzieh Ayati, Nicholas M Kaye, Mehmet Koyuturk, Eric Christian, Hillard M Lazarus, David Kaplan, Keming Gao, Joseph R Calabrese> ;Journal of Clinical Medicine. 2024 Mar 5
- 4 citationsContributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder.Himanshu K Mishra, Heather Wei, Kayla E Rohr, Insu Ko, Caroline M Nievergelt, Adam X Maihofer, Paul D Shilling, Martin Alda, Wade H Berrettini, Kristen J Brennand, Jos...> ;European Neuropsychopharmacology. 2023 Sep 1
- 1 citationsDifferences in intracellular protein levels in monocytes and CD4lymphocytes between bipolar depressed patients and healthy controls: A pilot study with tyramine-based ...Keming Gao, Marzieh Ayati, Nicholas M Kaye, Mehmet Koyuturk, Joseph R Calabrese, Stephen J Ganocy, Hillard M Lazarus, Eric Christian, David Kaplan> ;Journal of Affective Disorders. 2023 May 1
- Join now to see all
Journal Articles
- Subthreshold PTSD and PTSD in a Prospective‐Longitudinal Cohort of Military Personnel: Potential Targets for Preventive InterventionsIsrael Liberzon, Marijo B Tamburrino, Katherine M Keyes, Sandro Galea, Joseph R Calabrese, Depression and Anxiety
- Efficacy and safety of aripiprazole once-monthly in the maintenance treatment of bipolar I disorder: a double-blind, placebo-controlled, randomized withdrawal studyCalabrese JR, Sanchez R, Jin D, Amatniek J, Cox K, Johnson B, Perry, Hertal P, Salzman PM, McQuate RD, Nyilas M, Carson WH, J Clin Psychiatry, 1/31/2017
- Depression Severity and Quality of Life of Qualified and Unqualified Patients with a Mood Disorder for a Research Stuy Targeting Anhedonia in a Clinical SampleGao K, Sweet J, Su M, Calabrese J, Asian J Psychiatry, 1/1/2017
- Join now to see all
Books/Book Chapters
Lectures
- Monotherapy and Adjunctive Latuda for treatment of bipolar depression.Sau Paulo, Brazil - 1/18/2016
- Vincent van Gogh: Biography, Family History, and Artistic Genius.Cleveland Clinic - 1/1/2016
- Recognition and Treatment of Bipolar DisorderColombia; CARICAM; Mexico; Ecuador; Chile; Brazil; Argentina - 1/29/2015
- Join now to see all
Other
- Six subtle signs of depression you should never ignore.Calabrese JR
1/31/2016 - Westside Arts Festival Shines Light on Mental Illness and Addiction.Calabrese JR
1/19/2016 - Long-Acting Injectable Aripiprazole as a Potential Maintenance Treatment for Bipolar I Disorder.Calabrese JR, Otsuka and Lundbeck Data at ACNP Annual Meeting
1/17/2016 - Join now to see all
Press Mentions
- FDA Approves Abilify Maintena for Bipolar I Disorder Monotherapy TreatmentAugust 8th, 2017
- FDA Approves First Monthly Injectable for Bipolar DisorderJuly 31st, 2017
- LAI Aripiprazole Found to Reduce Recurrence of Mood EpisodesMarch 16th, 2017
- Join now to see all
Grant Support
- Psychosocial Intervention To Promote Treatment Adherence In CmchNational Institute Of Mental Health2007
- Phenomenology And Identification Of Juvenile BPD In A Community SettingNational Institute Of Mental Health2007
- Combination Therapy In Dual Diagnosis Rapid Cycling BPD In Both The Tertiary CareNational Institute Of Mental Health2007
- Bipolar Disorder Across The Life SpanNational Institute Of Mental Health2003–2007
- Combination Therapy In Bipolar Rapid CyclingNational Institute Of Mental Health2002–2004
- Valproate Versus Lithium In Bipolar Rapid CyclingNational Institute Of Mental Health1995–1999
- Valproate And Lithium In The Prophylaxis Of The Manic Phase Of Bipolar DisorderNational Institute Of Mental Health1996
Hospital Affiliations
- University Hospitals Cleveland Medical CenterCleveland, Ohio
- UH Regional HospitalsCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: